Integrated Micro-Chromatography Systems (IMCS) is a privately-held biotech company that designs, manufactures & distributes biological reagents from recombinant proteins to micro-chromatography products. The genetically modified, industry-disrupting IMCSzyme is used by clinical, forensic & pain care laboratories for drug detection in biological samples. IMCStips are advanced micro-chromatography products centered around patented dispersive solid-phase extraction technology for faster biochemical purification processes. IMCS clients include clinical & forensic toxicology labs, academic research facilities, US government agencies & life science companies worldwide. Recent NIH funds were awarded to IMCS to manufacture glycosyltransferases and leverage the company's advanced manufacturing and R&D capabilities to expand synthesis of glycosphingolipids and sialoglycans. This provides new product lines and delivers critically needed materials to the market.